These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8026274)

  • 1. Biliary lipid composition in heterozygous familial hypercholesterolemia and influence of treatment with probucol.
    Tanno N; Oikawa S; Koizumi M; Kotake H; Hirakawa H; Kanazawa Y; Toyota T
    Dig Dis Sci; 1994 Jul; 39(7):1586-91. PubMed ID: 8026274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary lipid composition in normo- and hyperlipoproteinemia.
    Ahlberg J; Angelin B; Einarsson K; Hellström K; Leijd B
    Gastroenterology; 1980 Jul; 79(1):90-4. PubMed ID: 7380228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
    Inagaki M; Nakagawa-Toyama Y; Nishida M; Nakatani K; Nakaoka H; Kawase M; Kawase R; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Komuro I; Yamashita S
    J Atheroscler Thromb; 2012; 19(7):643-56. PubMed ID: 22785024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of probucol of bile composition].
    Marecek Z; Jirsa M; Kordac V; Kucerová K
    Vnitr Lek; 1981 Jul; 27(7):667-70. PubMed ID: 7303501
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of clinofibrate, a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia.
    Takeuchi N; Kukita H; Kajiyama G; Fujiyama M; Ishikawa K; Miki H; Mishima T; Murata K; Asano T
    Atherosclerosis; 1982 Apr; 42(2-3):129-39. PubMed ID: 7073798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary lipid secretion in patients with heterozygous familial hypercholesterolemia and combined hyperlipidemia. Influence of bezafibrate and fenofibrate.
    Leiss O; Meyer-Krahmer K; von Bergmann K
    J Lipid Res; 1986 Jul; 27(7):713-23. PubMed ID: 3760707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Probucol treatment of hyperlipidemia].
    Koizumi J
    Nihon Rinsho; 1994 Dec; 52(12):3279-84. PubMed ID: 7853723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of heterozygous familial hypercholesterolemia with lipid-lowering drugs.
    Illingworth DR; Bacon S
    Arteriosclerosis; 1989; 9(1 Suppl):I121-34. PubMed ID: 2492189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, placebo-controlled, cross-over trial of probucol in heterozygous familial hypercholesterolaemia.
    Durrington PN; Miller JP
    Atherosclerosis; 1985 May; 55(2):187-94. PubMed ID: 3890872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profiles.
    Helve E; Tikkanen MJ
    Atherosclerosis; 1988 Aug; 72(2-3):189-97. PubMed ID: 3063268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
    Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
    Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary lipid composition in patients with porta cirrhosis of the liver.
    Angelin B; Einarsson K; Ewerth S; Leijd B
    Scand J Gastroenterol; 1980; 15(7):849-52. PubMed ID: 7209393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholic acid on the metabolism of endogenous plasma triglyceride and on biliary lipid composition in hyperlipoproteinemia.
    Angelin B; Leijd B
    J Lipid Res; 1980 Jan; 21(1):1-9. PubMed ID: 7354246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cerivastatin sodium, a new HMG-CoA reductase inhibitor, on biliary lipid metabolism in patients with hypercholesterolemia.
    Tazuma S; Yamashita G; Ochi H; Miura H; Kajihara T; Hattori Y; Miyake H; Nishioka T; Hyogo H; Sunami Y; Yasumiba S; Kajiyama G
    Clin Ther; 1998; 20(3):477-85. PubMed ID: 9663363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment with cholestyramine and nicotinic acid in heterozygous familial hypercholesterolaemia: effects on biliary lipid composition.
    Angelin B; Eriksson M; Einarsson K
    Eur J Clin Invest; 1986 Oct; 16(5):391-6. PubMed ID: 3100307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism and plasma cholesterol response to probucol.
    Nestruck AC; Bouthillier D; Sing CF; Davignon J
    Metabolism; 1987 Aug; 36(8):743-7. PubMed ID: 3600286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ileal resection on biliary lipids and bile acid composition in patients with Crohn's disease.
    Lapidus A; Einarsson K
    Gut; 1991 Dec; 32(12):1488-91. PubMed ID: 1773954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of octreotide on biliary lipid composition and occurrence of cholesterol crystals in patients with acromegaly. A prospective study.
    Erlinger S; Chanson P; Dumont M; Ponsot P; Warnet A; Harris AG
    Dig Dis Sci; 1994 Nov; 39(11):2384-8. PubMed ID: 7956607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine determination of biliary lipid composition with the entero-test.
    Muraca M; Pazzi P; Vilei MT; Miconi L; Granato A; Cianci V; Sighinolfi D; Alvisi A; Gerunda G; Maffei Faccioli A
    Ann Chir; 1994; 48(2):197-200. PubMed ID: 8192414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
    Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S
    Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.